Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Cyteir Therapeutics
763E Concord Avenue
Cambridge, MA 02138
Phone: 857-285-4140
http://cyteir.com

Cyteir Therapeutics is a leader in the discovery and development of novel therapeutics based on the biology of DNA repair and synthetic lethality for the treatment of cancer and autoimmune diseases. The company's initial approach takes advantage of the "gain-of-function" from DNA damage overload to induce selective self-destruction of cells by targeting disease-induced RAD51 transport. Cyteir's lead molecules were initially discovered using the company's drug discovery platform, which enables identification of primary cells with tunable genetic constraints.

Key Contact
NameTitleE-Mail
Kevin Mills, Ph.D.Co-Founderkevin.mills@cyteir.com


Funding Events
DateAmountTypeInvestors
03/08/18$29,000,000Series B Celgene Corporation
DROIA Oncology Ventures
Lightstone Ventures
Venrock  
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.